Skip to main content

iSpecimen, Inc. (ISPC)

NASDAQ: ISPC · IEX Real-Time Price · USD
7.31 -0.25 (-3.31%)
Oct 22, 2021 4:00 PM EDT - Market closed
Market Cap51.23M
Revenue (ttm)10.84M
Net Income (ttm)n/a
Shares Out1.61M
EPS (ttm)-7.42
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume37,767
Open7.49
Previous Close7.56
Day's Range7.17 - 7.50
52-Week Range5.10 - 10.00
Betan/a
Analystsn/a
Price Targetn/a
Est. Earnings DateNov 10, 2021

About ISPC

iSpecimen is technology-driven company founded to address a critical challenge: how to connect life science researchers who need human biofluids, tissues, and living cells (“biospecimens”) for their research, with the billions of biospecimens available (but not easily accessible) in healthcare provider organizations worldwide. Our ground-breaking iSpecimen Marketplace platform was designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. The iSpecimen Marketplace brings new capabilitie...

IndustryDiagnostics & Research
IPO DateJun 17, 2021
CEOChristopher Ianelli
Employees41
Stock ExchangeNASDAQ
Ticker SymbolISPC
Full Company Profile

Financial Performance

In 2020, iSpecimen's revenue was $8.18 million, an increase of 90.40% compared to the previous year's $4.30 million. Losses were -$4.65 million, -1.59% less than in 2019.

Financial Statements

News

iSpecimen® to Report Third Quarter 2021 Results on November 4, 2021

LEXINGTON, Mass., Oct. 21, 2021 /PRNewswire/ -- iSpecimen Inc.  (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced that it will report its finan...

1 day ago - PRNewsWire

iSpecimen Expands Global Biospecimen Supplier Network and Access to Human Biospecimens Needed to Help Accelerate Deve...

LEXINGTON, Mass., Oct. 7, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC), an online marketplace for human biospecimens  ("iSpecimen" or the "Company"), today announced it is expanding its human bios...

2 weeks ago - PRNewsWire

iSpecimen Announces Inclusion in Russell Microcap® Index

LEXINGTON, Mass., Sept. 14, 2021 /PRNewswire/ --  iSpecimen Inc.  (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced that it will be included in...

1 month ago - PRNewsWire

iSpecimen to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference on September 13-15, 2021

LEXINGTON, Mass., Sept. 1, 2021 /PRNewswire/ --  iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced that Christopher Ianelli, MD,...

1 month ago - PRNewsWire

iSpecimen Expands Human Biospecimen Offerings for Cancer Researchers

LEXINGTON, Mass., Aug. 18, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC), an online marketplace for human biospecimens  ("iSpecimen" or the "Company"), today announced it has grown its cancer-relat...

2 months ago - PRNewsWire

iSpecimen Inc. Interview to Air on the RedChip Money Report® on Bloomberg TV

LEXINGTON, Mass., Aug. 12, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC), an online marketplace for human biospecimens ("iSpecimen" or the "Company"), today announced that an interview with its CEO...

2 months ago - PRNewsWire

iSpecimen Reports Second Quarter 2021 Financial Results

LEXINGTON, Mass., Aug. 10, 2021 /PRNewswire/ --  iSpecimen Inc.  (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today reported its financial results for the...

2 months ago - PRNewsWire

iSpecimen Launches Enhanced Custom Collection Service

LEXINGTON, Mass., July 29, 2021 /PRNewswire/ --  iSpecimen   Inc.  (Nasdaq: ISPC), an online marketplace for human biospecimens ("iSpecimen" or the "Company"), today announced that it has enhanced its c...

2 months ago - PRNewsWire

iSpecimen to Report Second Quarter 2021 Results on August 10, 2021

LEXINGTON, Mass., July 27, 2021 /PRNewswire/ --  iSpecimen Inc.  (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced that it will report its fina...

2 months ago - PRNewsWire

iSpecimen Announces Closing of Over-Allotment Option in Connection with its Initial Public Offering

LEXINGTON, Mass., July 1, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced the closing of the issuance of ...

3 months ago - PRNewsWire

iSpecimen Announces Closing of Initial Public Offering

LEXINGTON, Mass., June 21, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced the closing of its previously ...

4 months ago - PRNewsWire

iSpecimen Announces Pricing of Initial Public Offering

iSpecimen Inc. ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced the pricing of its initial public...

4 months ago - PRNewswire

iSpecimen IPO Registration Document (S-1)

iSpecimen, Inc. has filed to go public with an IPO on the NASDAQ.

6 months ago - SEC

IPO Preview: iSpecimen Starts $20 Million U.S. IPO Effort

Lexington, Massachusetts-based iSpecimen was founded to create a marketplace connecting biopharmaceutical and academic researchers with a large selection of human biospecimens and related information.

10 months ago - TheStreet